Chronic Dry Eye Disease
Dry Eye Defense: The Role of Nutraceuticals
This activity is supported by an educational grant from Bausch + Lomb.
MedEd Talks: Ocular Surface and Lid Health Collaborative Care
This activity is supported by educational grants from Tarsus Pharmaceuticals, Inc. and Viatris, Inc.
Ace The Case: A 67-Year-Old Woman With Blurred Vision
This activity is supported by an educational grant from Dompé US, Inc.
Patient Education and Support
Nutraceuticals for Dry Eye: Dispelling the Dogma and Embracing the Data
This activity is supported by an educational grant from Bausch + Lomb.
Eyenovia, SGN Nanopharma to develop treatment for dry eye disease
Eyenovia and SGN Nanopharma have announced a collaboration agreement to develop a new drug-device combination product for chronic dry eye disease.
Amring Pharmaceuticals changes name to Nordic Pharma
Amring Pharmaceuticals has changed its name to Nordic Pharma following its recent acquisition by Nordic Group, part of a strategy to expand the parent company’s branded and generic eye care products in the U.S. and abroad.
Dry Eye Disease and Meibomian Gland Dysfunction: Imperfect Together
This activity is supported by an educational grant from Bausch + Lomb.
VIDEO: Vevye demonstrates bioavailability, tolerability in dry eye treatment
TAMPA, Fla. — In this Healio Video Perspective from Telling It Like It Is, Priya M. Mathews, MD, MPH, explains why she offers Vevye for the treatment of dry eye disease.
Harrow licenses 5 ophthalmic products to Canada-based Apotex
Harrow has announced an exclusive out-licensing agreement with Apotex, a major Canadian pharmaceutical company, to market and distribute five of the company’s branded ophthalmic products.